Nutex Health (NUTX) Capital Expenditures (2011 - 2026)

Nutex Health (NUTX) has 13 years of Capital Expenditures data on file, last reported at $1.2 million in Q1 2026.

• Quarterly Capital Expenditures rose 1776.56% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 124.04% YoY) and the FY2025 annual result came in at $2.5 million, up 9.64% from the prior year.
• Capital Expenditures retreated to $1.2 million in Q1 2026 per NUTX's latest filing, from $1.4 million in the prior quarter.
• The five-year high for Capital Expenditures was $8.6 million in Q1 2022, with the low at -$7.9 million in Q4 2022.
• Average Capital Expenditures over 5 years is $1.8 million, with a median of $751000.0 recorded in 2025.
• Year-over-year, Capital Expenditures plunged 167.23% in 2022 and surged 1776.56% in 2026.
• Nutex Health's Capital Expenditures stood at -$7.9 million in 2022, then soared by 89.52% to -$825487.0 in 2023, then jumped by 147.85% to $395000.0 in 2024, then soared by 256.71% to $1.4 million in 2025, then dropped by 14.76% to $1.2 million in 2026.
• Business Quant data shows NUTX's Capital Expenditures at $1.2 million in Q1 2026, $1.4 million in Q4 2025, and $302000.0 in Q3 2025.